{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:38:23Z","timestamp":1783633103934,"version":"3.55.0"},"reference-count":39,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,1]]},"DOI":"10.1210\/jc.2016-3732","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T11:11:03Z","timestamp":1492600263000},"page":"1486-1494","source":"Crossref","is-referenced-by-count":32,"title":["Functional Imaging in the Follow-Up of Enteropancreatic Neuroendocrine Tumors: Clinical Usefulness and Indications"],"prefix":"10.1210","volume":"102","author":[{"given":"Elettra","family":"Merola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne E.","family":"Pavel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Panzuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Capurso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Cicchese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Rinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Gress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Iannicelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Prosperi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Pizzichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Kump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Lipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Partelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Falconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram","family":"Wiedenmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Delle Fave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2017,1,13]]},"reference":[{"issue":"1","key":"key\n\t\t\t\t20170505135332_B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000442207","article-title":"Trends in incidence of neuroendocrine neoplasms in Norway: a report of 16,075 cases from 1993 through 2010","volume":"104","year":"2017","journal-title":"Neuroendocrinology"},{"issue":"18","key":"key\n\t\t\t\t20170505135332_B2","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","year":"2008","journal-title":"J Clin Oncol"},{"issue":"4","key":"key\n\t\t\t\t20170505135332_B3","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1677\/ERC-10-0152","article-title":"Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters","volume":"17","year":"2010","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"key\n\t\t\t\t20170505135332_B4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/MPA.0000000000000032","article-title":"Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcome","volume":"43","year":"2014","journal-title":"Pancreas"},{"issue":"2","key":"key\n\t\t\t\t20170505135332_B5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000167796","article-title":"Somatostatin receptor subtypes 2 and 5 are associated with better survival in well-differentiated endocrine carcinomas","volume":"89","year":"2009","journal-title":"Neuroendocrinology"},{"issue":"3","key":"key\n\t\t\t\t20170505135332_B6","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1007\/s00330-015-3882-1","article-title":"Comparison of diagnostic accuracy of 111In-pentetreotide SPECT and 68Ga-DOTATOC PET\/CT: a lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours","volume":"26","year":"2016","journal-title":"Eur Radiol"},{"issue":"8","key":"key\n\t\t\t\t20170505135332_B7","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1007\/s00259-012-2146-4","article-title":"Is 68Ga-DOTA-NOC PET\/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour?","volume":"39","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"key\n\t\t\t\t20170505135332_B8","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.2967\/jnumed.115.162719","article-title":"Prognostic value of 68Ga-DOTANOC PET\/CT SUVmax in patients with neuroendocrine tumours of the pancreas","volume":"56","year":"2015","journal-title":"J Nucl Med"},{"issue":"4","key":"key\n\t\t\t\t20170505135332_B9","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1159\/000323762","article-title":"Incremental diagnostic value and impact on patient management of somatostatin receptor scintigraphy with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors","volume":"20","year":"2011","journal-title":"Med Princ Pract"},{"issue":"2","key":"key\n\t\t\t\t20170505135332_B10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrendo.2013.246","article-title":"Neuroendocrine tumours: the role of imaging for diagnosis and therapy","volume":"10","year":"2014","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"key\n\t\t\t\t20170505135332_B11","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1007\/s00330-011-2199-y","article-title":"Role of 68Ga-DOTATOC PET-CT in the diagnosis and staging of pancreatic neuroendocrine tumours","volume":"21","year":"2011","journal-title":"Eur Radiol"},{"issue":"10","key":"key\n\t\t\t\t20170505135332_B12","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.ejrad.2015.06.024","article-title":"Clinical value of 68Ga-DOTATATE-PET\/CT compared to stand-alone contrast enhanced CT for the detection of extra-hepatic metastases in patients with neuroendocrine tumours (NET)","volume":"84","year":"2015","journal-title":"Eur J Radiol"},{"issue":"10","key":"key\n\t\t\t\t20170505135332_B13","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00259-007-0450-1","article-title":"Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours","volume":"34","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"key\n\t\t\t\t20170505135332_B14","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1200\/JCO.2005.08.066","article-title":"Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors","volume":"23","year":"2005","journal-title":"J Clin Oncol"},{"issue":"28","key":"key\n\t\t\t\t20170505135332_B15","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","article-title":"Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group","volume":"27","author":"PROMID Study Group","year":"2009","journal-title":"J Clin Oncol"},{"issue":"3","key":"key\n\t\t\t\t20170505135332_B16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1316158","article-title":"Lanreotide in metastatic enteropancreatic neuroendocrine tumors","volume":"371","author":"CLARINET Investigators","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170505135332_B17"},{"issue":"2","key":"key\n\t\t\t\t20170505135332_B18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","year":"2009","journal-title":"Eur J Cancer"},{"issue":"1","key":"key\n\t\t\t\t20170505135332_B19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.beem.2016.02.001","article-title":"Management of follow-up of neuroendocrine neoplasias","volume":"30","year":"2016","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t20170505135332_B20","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.clinimag.2011.11.005","article-title":"Are RECIST criteria sufficient to assess response to therapy in neuroendocrine tumors?","volume":"36","year":"2012","journal-title":"Clin Imaging"},{"issue":"2","key":"key\n\t\t\t\t20170505135332_B21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000443171","article-title":"ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors","volume":"103","author":"Vienna Consensus Conference participants","year":"2016","journal-title":"Neuroendocrinology"},{"issue":"2","key":"key\n\t\t\t\t20170505135332_B22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000443170","article-title":"ENETS consensus guidelines update for neuroendocrine neoplasms of the jejunum and ileum","volume":"103","author":"Vienna Consensus Conference participants","year":"2016","journal-title":"Neuroendocrinology"},{"key":"key\n\t\t\t\t20170505135332_B23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000225952","article-title":"ENETS consensus guidelines for the standards of care in neuroendocrine tumours: follow-up and documentation","volume":"90","author":"Mallorca Consensus Conference participants","year":"2009","journal-title":"Neuroendocrinology"},{"issue":"6","key":"key\n\t\t\t\t20170505135332_B24","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000085237","article-title":"Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS)","volume":"80","author":"European Neuroendocrine Tumour Society","year":"2004","journal-title":"Neuroendocrinology"},{"issue":"5","key":"key\n\t\t\t\t20170505135332_B25","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s00330-015-3941-7","article-title":"Pancreatic neuroendocrine tumour (PNET): staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma","volume":"26","year":"2016","journal-title":"Eur Radiol"},{"issue":"12","key":"key\n\t\t\t\t20170505135332_B26","first-page":"BP140","article-title":"111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging","volume":"30","author":"Oncology Committee of the EANM","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"key\n\t\t\t\t20170505135332_B27","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.2967\/jnumed.107.040378","article-title":"Processing of generator-produced 68Ga for medical application","volume":"48","year":"2007","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t20170505135332_B28"},{"issue":"10","key":"key\n\t\t\t\t20170505135332_B29","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1007\/s00259-010-1512-3","article-title":"Procedure guidelines for PET\/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE","volume":"37","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"key\n\t\t\t\t20170505135332_B30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00428-006-0250-1","article-title":"TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system","volume":"449","author":"all other Frascati Consensus Conference participants","year":"2006","journal-title":"Virchows Arch"},{"issue":"4","key":"key\n\t\t\t\t20170505135332_B31","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00428-007-0452-1","article-title":"TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system","volume":"451","year":"2007","journal-title":"Virchows Arch"},{"issue":"2-3","key":"key\n\t\t\t\t20170505135332_B32","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000074519","article-title":"Influence of somatostatin receptor scintigraphy and CT\/MRI on the clinical management of patients with gastrointestinal neuroendocrine tumors: an analysis in 188 patients","volume":"68","year":"2003","journal-title":"Digestion"},{"issue":"5","key":"key\n\t\t\t\t20170505135332_B33","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2967\/jnumed.115.163865","article-title":"Safety and efficacy of 68Ga-DOTATATE PET\/CT for diagnosis, staging, and treatment management of neuroendocrine tumors","volume":"57","year":"2016","journal-title":"J Nucl Med"},{"issue":"6","key":"key\n\t\t\t\t20170505135332_B34","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1200\/JCO.2015.64.0987","article-title":"Prospective study of 68Ga-DOTATATE positron emission tomography\/computed tomography for detecting gastro-entero-pancreatic neuroendocrine tumors and unknown primary sites","volume":"34","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"key\n\t\t\t\t20170505135332_B35","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2967\/jnumed.115.166017","article-title":"The impact of 68Ga-DOTATATE PET\/CT imaging on management of patients with neuroendocrine tumours: experience from a national referral centre in the United Kingdom","volume":"57","year":"2016","journal-title":"J Nucl Med"},{"issue":"2","key":"key\n\t\t\t\t20170505135332_B36","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1148\/radiol.13122501","article-title":"Neuroendocrine tumor recurrence: diagnosis with 68Ga-DOTATATE PET\/CT","volume":"270","year":"2014","journal-title":"Radiology"},{"issue":"1","key":"key\n\t\t\t\t20170505135332_B37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000265561","article-title":"Impact of multiphase 68Ga-DOTATOC-PET\/CT on therapy management in patients with neuroendocrine tumors","volume":"91","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"1","key":"key\n\t\t\t\t20170505135332_B38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00259-011-1935-5","article-title":"Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET\/CT for staging enteropancreatic neuroendocrine tumours","volume":"39","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"key\n\t\t\t\t20170505135332_B39","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/annonc\/mdg160","article-title":"Staging of digestive endocrine tumours using helical computed tomography and somatostatin receptor scintigraphy","volume":"14","year":"2003","journal-title":"Ann Oncol"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T05:01:50Z","timestamp":1569042110000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article-lookup\/doi\/10.1210\/jc.2016-3732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,13]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,1,13]]},"published-print":{"date-parts":[[2017,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2016-3732","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,13]]}}}